Bayan Health vs Found
Bayan Health costs $50 less a month, and both sell semaglutide, tirzepatide and orforglipron.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Bayan Health
Best for: a priced catalog across microdose, standard, oral drop and tablet routes
Visit Bayan Health →
If you are choosing between Bayan Health and Found, the first difference is cost: Bayan Health is $50 a month cheaper at the entry price. Both prescribe semaglutide, tirzepatide and orforglipron, so moving from one to the other would not change your drug. Found leads our six-part score, 8.6 to 8.2.
Bayan Health vs Found price
Bayan Health is the cheaper way in: $99 a month against $149 a month at Found. That is $50 less each month (34% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Bayan Health ($99 a month vs $169 a month); tirzepatide is cheaper at Bayan Health ($119 a month vs $169 a month); orforglipron is cheaper at Found ($149 a month vs $269 a month).
Medications and formats
Both sell semaglutide, tirzepatide and orforglipron.
On format, Bayan Health prices compounded injections, while Found prices compounded injections, an oral option and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Found is the only one of the two with a brand-name price.
Where each one treats patients
Bayan Health does not publish where it ships, and Found lists 50 states.
Pricing
Bayan Health
Catalog: "Microdose Semaglutide GLP-1 + Vitamin B6 — $99.00 / month".
Catalog: "Semaglutide GLP-1 + Vitamin B6 — $129.00 / month".
Catalog: "Microdose Tirzepatide GLP-1/GIP + Vitamin B6 — $119.00 / month".
Catalog: "Tirzepatide GLP-1/GIP + Vitamin B6 — $149.00 / month".
Catalog: "Oral Drops Semaglutide GLP-1 — $99.00 / month".
Catalog: "Oral Drops Tirzepatide GLP-1/GIP — $119.00 / month".
Catalog: "Orforglipron Oral Tablets — $269.00 / month". The listing does not say whether this is the approved brand or a compounded preparation.
Found
$169/mo cash-pay on the 12-month prepaid plan, with medication, membership and coaching included; $99/mo with insurance on the same 12-month prepaid plan. Month-to-month: $199/mo with insurance, $289/mo cash. A '$100 off today' promo was running at checkout.
Same Compounded GLP-1 Plan price as semaglutide, with no per-drug price published; the drug and price are set after intake. Cash: $169/mo prepaid for 12 months or $289/mo month to month. Insurance: $99/mo prepaid.
Starting cash price of about $149/mo, listed on Found's Foundayo comparison table. Newly added to Found's menu.
Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.
Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.
Brand-name Ozempic at $1,100/mo, as advertised on the homepage.
Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.
What each price covers
Both prices cover the clinician visit and the medication itself.
Bayan Health's price also covers shipping, which Found does not claim.
Found's price also covers coaching, which Bayan Health does not claim.
Bayan Health is silent on lab work and coaching.
Found is silent on shipping and lab work.
Bayan Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Found
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, Found scores 8.6 and Bayan Health 8.2 out of 10.
Bayan Health is stronger on value (10.0 vs 7.8).
Found is stronger on trust & safety (8.5 vs 5.5) and accessibility (10.0 vs 5.0).
Effectiveness, user experience and support are within half a point.
Bayan Health
8.2/10
Found
8.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Bayan Health nor Found has an FDA warning letter on record with us.
Features & Coverage
| Feature | Bayan Health | Found |
|---|---|---|
| Starting Price | ✓$99/mo | $149/mo |
| Features | ✓5 features | 3 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Bayan Health
Bayan Health publishes a full shop-style catalog rather than a plan card: microdose semaglutide and tirzepatide with B6 at $99 and $119, standard doses at $129 and $149, oral drops at $99 and $119, and Orforglipron Oral Tablets at $269. It states no memberships, no dose-based price increases and no hidden fees, and says its medications come from US 503A pharmacy partners without naming them. Its Terms name no operating entity.
Read our full Bayan Health review →About Found
Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.
Read our full Found review →Pros & Cons
Bayan Health
What we like
- Semaglutide costs $99 a month, 46% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $119 a month, 52% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Bayan Health
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Found
What we like
- Tirzepatide costs $169 a month, 32% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and coaching
- Serves all 50 states
- We found no FDA warning letters issued to Found
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Found wins this one, 8.6 to 8.2, above all for tirzepatide at $169/month, 37% below the typical price. Bayan Health undercuts it by $50 a month, so if the monthly bill is what decides it, Bayan Health is the pick. Bayan Health fits better if a priced catalog across microdose, standard, oral drop and tablet routes is your priority.
Choose Bayan Health if…
You want a priced catalog across microdose, standard, oral drop and tablet routes and an opening price near $99 a month.
Choose Found if…
You want tirzepatide at $169/month, 37% below the typical price and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →Bayan Health vs Found: FAQ
Close alternatives to Bayan Health and Found
- Bayan Health vs PreventiveMD
- Bayan Health vs ShedRx
- Bayan Health vs Kin Meds
- Found vs Sesame Care
- Found vs ShedRx
- Found vs Kin Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.